The cell separation market size has grown rapidly in recent years. It will grow from $15.43 billion in 2025 to $18.2 billion in 2026 at a compound annual growth rate (CAGR) of 18%. The growth in the historic period can be attributed to expansion of cancer research programs, growth in stem cell research, rising adoption of flow cytometry, increased demand for diagnostic cell separation, wider availability of separation consumables.
The cell separation market size is expected to see rapid growth in the next few years. It will grow to $35.75 billion in 2030 at a compound annual growth rate (CAGR) of 18.4%. The growth in the forecast period can be attributed to increasing investments in cell-based therapies, growing demand for precision diagnostics, expansion of immunotherapy research, rising use of automated clinical laboratories, increasing adoption of personalized medicine approaches. Major trends in the forecast period include increasing adoption of magnetic and fluorescence-based sorting techniques, rising demand for high-purity cell populations, growing use of automated cell separation systems, expansion of single-cell isolation applications, enhanced focus on clinical-grade cell processing.
The growing shift toward personalized medicine is anticipated to drive the expansion of the cell separation market in the coming years. Personalized medicine, also referred to as precision medicine, is an advanced approach to healthcare that considers individual differences in patients’ genetic makeup, environment, and lifestyle when designing treatments. This approach can enhance cell separation processes in multiple ways by enabling more precise and patient-specific methods in biomedical research and therapeutic applications. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the Food and Drug Administration (FDA) approved seven new personalized cancer treatments in 2023 out of a total of 26 personalized therapies, representing a notable increase compared to the 12 approvals in 2022. Therefore, the increasing adoption of personalized medicine is fueling the growth of the cell separation market.
Major companies operating in the cell separation market are concentrating on technological innovations, such as microfluidic rare cell enrichment, to enhance the isolation, analysis, and downstream use of rare cells and circulating tumor cells (CTCs) in cancer research and diagnostics. Microfluidic rare cell enrichment involves the use of microscale fluidic devices to selectively isolate and concentrate rare cells from complex biological samples for accurate analysis and diagnostic applications. For instance, in June 2024, Bio-Rad Laboratories, a US-based life sciences company, introduced Celselect Slides 2 to improve the capture and isolation of rare cells. These advanced slides enable more efficient enrichment of CTCs, supporting high-precision cancer research workflows and accelerating the development of targeted therapies. The launch of Celselect Slides 2 highlights Bio-Rad’s commitment to advancing cell separation technologies and supporting innovative cancer research.
In June 2025, STEMCELL Technologies, a Canada-based life sciences company, acquired Cellular Highways for an undisclosed sum. Through this acquisition, STEMCELL Technologies aims to broaden its cell biology product portfolio, improve access to advanced cell culture technologies, and accelerate innovation in cellular research. Cellular Highways is a US-based technology company that specializes in advanced cell culture systems and automated cell handling solutions.
Major companies operating in the cell separation market are Becton Dickinson and Company, Merck KGaA, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Terumo Corporation, Miltenyi Biotec GmbH, Beckman Coulter Inc., STEMCELL Technologies Inc., PluriSelect Life Science UG and Co. KG, GE HealthCare Technologies Inc., Life Technologies Inc., Danaher Corporation, Corning Incorporated, Sartorius AG, Bio-Techne Corp., Takara Bio Inc., Lonza Group Ltd., MagBio Genomics, Akadeum Life Sciences Inc., Invent Biotechnologies Inc.
North America was the largest region in the cell separation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the cell separation market report during the forecast period. The regions covered in the cell separation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cell separation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the cell separation market by increasing costs of imported flow cytometers, magnetic separators, antibodies, consumables, and automated sorting platforms. Hospitals, research institutes, and biotech companies in North America and Europe are most affected due to dependence on imported high-end instruments, while Asia-Pacific faces higher costs for scaling diagnostic and therapeutic applications. These tariffs are raising procurement costs and slowing technology upgrades. At the same time, they are supporting regional manufacturing of consumables, local assembly of instruments, and development of more cost-efficient cell separation technologies.
The cell separation market research report is one of a series of new reports that provides cell separation market statistics, including cell separation industry global market size, regional shares, competitors with a cell separation market share, detailed cell separation market segments, market trends and opportunities, and any further data you may need to thrive in the cell separation industry. This cell separation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Cell separation is the process of isolating one or more specific cell types from a heterogeneous cell mixture. It is used to identify, extract, and transfer targeted cells from complex cell populations for purposes such as research, diagnosis, and treatment.
The main types of cells involved in cell separation are human cells and animal cells. Human cells refer to the basic structural and functional units of the human body. Cell separation is performed using various techniques, including gradient centrifugation, surface marker-based separation, fluorescence-activated cell sorting, and magnetic cell sorting. The product types include consumables and instruments, which are used across applications such as biomolecule isolation, cancer research, stem cell research, tissue regeneration, in vitro diagnostics, and therapeutics.
The cell separation market consists of revenues earned by entities by providing immunomagnetic cell separation, immunodensity cell separation, microfluidic cell separation, and sedimentation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell separation market also includes sales of kits, buffers, strainers, separation devices, and accessories used in providing cell separation services. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The cell separation market size is expected to see rapid growth in the next few years. It will grow to $35.75 billion in 2030 at a compound annual growth rate (CAGR) of 18.4%. The growth in the forecast period can be attributed to increasing investments in cell-based therapies, growing demand for precision diagnostics, expansion of immunotherapy research, rising use of automated clinical laboratories, increasing adoption of personalized medicine approaches. Major trends in the forecast period include increasing adoption of magnetic and fluorescence-based sorting techniques, rising demand for high-purity cell populations, growing use of automated cell separation systems, expansion of single-cell isolation applications, enhanced focus on clinical-grade cell processing.
The growing shift toward personalized medicine is anticipated to drive the expansion of the cell separation market in the coming years. Personalized medicine, also referred to as precision medicine, is an advanced approach to healthcare that considers individual differences in patients’ genetic makeup, environment, and lifestyle when designing treatments. This approach can enhance cell separation processes in multiple ways by enabling more precise and patient-specific methods in biomedical research and therapeutic applications. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the Food and Drug Administration (FDA) approved seven new personalized cancer treatments in 2023 out of a total of 26 personalized therapies, representing a notable increase compared to the 12 approvals in 2022. Therefore, the increasing adoption of personalized medicine is fueling the growth of the cell separation market.
Major companies operating in the cell separation market are concentrating on technological innovations, such as microfluidic rare cell enrichment, to enhance the isolation, analysis, and downstream use of rare cells and circulating tumor cells (CTCs) in cancer research and diagnostics. Microfluidic rare cell enrichment involves the use of microscale fluidic devices to selectively isolate and concentrate rare cells from complex biological samples for accurate analysis and diagnostic applications. For instance, in June 2024, Bio-Rad Laboratories, a US-based life sciences company, introduced Celselect Slides 2 to improve the capture and isolation of rare cells. These advanced slides enable more efficient enrichment of CTCs, supporting high-precision cancer research workflows and accelerating the development of targeted therapies. The launch of Celselect Slides 2 highlights Bio-Rad’s commitment to advancing cell separation technologies and supporting innovative cancer research.
In June 2025, STEMCELL Technologies, a Canada-based life sciences company, acquired Cellular Highways for an undisclosed sum. Through this acquisition, STEMCELL Technologies aims to broaden its cell biology product portfolio, improve access to advanced cell culture technologies, and accelerate innovation in cellular research. Cellular Highways is a US-based technology company that specializes in advanced cell culture systems and automated cell handling solutions.
Major companies operating in the cell separation market are Becton Dickinson and Company, Merck KGaA, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Terumo Corporation, Miltenyi Biotec GmbH, Beckman Coulter Inc., STEMCELL Technologies Inc., PluriSelect Life Science UG and Co. KG, GE HealthCare Technologies Inc., Life Technologies Inc., Danaher Corporation, Corning Incorporated, Sartorius AG, Bio-Techne Corp., Takara Bio Inc., Lonza Group Ltd., MagBio Genomics, Akadeum Life Sciences Inc., Invent Biotechnologies Inc.
North America was the largest region in the cell separation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the cell separation market report during the forecast period. The regions covered in the cell separation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cell separation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the cell separation market by increasing costs of imported flow cytometers, magnetic separators, antibodies, consumables, and automated sorting platforms. Hospitals, research institutes, and biotech companies in North America and Europe are most affected due to dependence on imported high-end instruments, while Asia-Pacific faces higher costs for scaling diagnostic and therapeutic applications. These tariffs are raising procurement costs and slowing technology upgrades. At the same time, they are supporting regional manufacturing of consumables, local assembly of instruments, and development of more cost-efficient cell separation technologies.
The cell separation market research report is one of a series of new reports that provides cell separation market statistics, including cell separation industry global market size, regional shares, competitors with a cell separation market share, detailed cell separation market segments, market trends and opportunities, and any further data you may need to thrive in the cell separation industry. This cell separation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Cell separation is the process of isolating one or more specific cell types from a heterogeneous cell mixture. It is used to identify, extract, and transfer targeted cells from complex cell populations for purposes such as research, diagnosis, and treatment.
The main types of cells involved in cell separation are human cells and animal cells. Human cells refer to the basic structural and functional units of the human body. Cell separation is performed using various techniques, including gradient centrifugation, surface marker-based separation, fluorescence-activated cell sorting, and magnetic cell sorting. The product types include consumables and instruments, which are used across applications such as biomolecule isolation, cancer research, stem cell research, tissue regeneration, in vitro diagnostics, and therapeutics.
The cell separation market consists of revenues earned by entities by providing immunomagnetic cell separation, immunodensity cell separation, microfluidic cell separation, and sedimentation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell separation market also includes sales of kits, buffers, strainers, separation devices, and accessories used in providing cell separation services. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Cell Separation Market Characteristics
3. Cell Separation Market Supply Chain Analysis
4. Global Cell Separation Market Trends and Strategies
5. Cell Separation Market Analysis of End Use Industries
7. Global Cell Separation Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Cell Separation Total Addressable Market (TAM) Analysis for the Market
9. Cell Separation Market Segmentation
10. Cell Separation Market Regional and Country Analysis
11. Asia-Pacific Cell Separation Market
12. China Cell Separation Market
13. India Cell Separation Market
14. Japan Cell Separation Market
15. Australia Cell Separation Market
16. Indonesia Cell Separation Market
17. South Korea Cell Separation Market
18. Taiwan Cell Separation Market
19. South East Asia Cell Separation Market
20. Western Europe Cell Separation Market
21. UK Cell Separation Market
22. Germany Cell Separation Market
23. France Cell Separation Market
24. Italy Cell Separation Market
25. Spain Cell Separation Market
26. Eastern Europe Cell Separation Market
27. Russia Cell Separation Market
28. North America Cell Separation Market
29. USA Cell Separation Market
30. Canada Cell Separation Market
31. South America Cell Separation Market
32. Brazil Cell Separation Market
33. Middle East Cell Separation Market
34. Africa Cell Separation Market
36. Cell Separation Market Competitive Landscape and Company Profiles
37. Cell Separation Market Other Major and Innovative Companies
40. Cell Separation Market High Potential Countries, Segments and Strategies
41. Appendix
Executive Summary
Cell Separation Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses cell separation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for cell separation? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cell separation market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Cell Type: Human Cells; Animal Cells2) By Method: Gradient Centrifugation; Surface Markers Separation; Fluorescence Activated Cell Sorting; Magnetic Cell Sorting
3) By Product: Consumables; Instruments
4) By Application: Biomolecule Isolation; Cancer Research; Stem Cell Research; Tissue Regeneration; In Vitro Diagnostics; Therapeutics
Subsegments:
1) By Human Cells: Blood Cells; Stem Cells; Tumor Cells2) By Animal Cells: Mammalian Cells; Avian Cells; Insect Cells
Companies Mentioned: Becton Dickinson and Company; Merck KGaA; Thermo Fisher Scientific Inc.; Bio-Rad Laboratories Inc.; Terumo Corporation; Miltenyi Biotec GmbH; Beckman Coulter Inc.; STEMCELL Technologies Inc.; PluriSelect Life Science UG and Co. KG; GE HealthCare Technologies Inc.; Life Technologies Inc.; Danaher Corporation; Corning Incorporated; Sartorius AG; Bio-Techne Corp.; Takara Bio Inc.; Lonza Group Ltd.; MagBio Genomics; Akadeum Life Sciences Inc.; Invent Biotechnologies Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Cell Separation market report include:- Becton Dickinson and Company
- Merck KGaA
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories Inc.
- Terumo Corporation
- Miltenyi Biotec GmbH
- Beckman Coulter Inc.
- STEMCELL Technologies Inc.
- PluriSelect Life Science UG and Co. KG
- GE HealthCare Technologies Inc.
- Life Technologies Inc.
- Danaher Corporation
- Corning Incorporated
- Sartorius AG
- Bio-Techne Corp.
- Takara Bio Inc.
- Lonza Group Ltd.
- MagBio Genomics
- Akadeum Life Sciences Inc.
- Invent Biotechnologies Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 18.2 Billion |
| Forecasted Market Value ( USD | $ 35.75 Billion |
| Compound Annual Growth Rate | 18.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
